MENLO
PARK, Calif., Dec. 11,
2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading
developer of high-quality, highly accurate sequencing solutions,
announced today that David Botstein,
Ph.D., a member of PacBio's Board of Directors, has retired from
his position effective December 7,
2023.
"I would like to thank David for his dedication to PacBio since
he joined the Board in 2012," said Christian Henry, President and Chief Executive
Officer. "His deep understanding of genomics and broad experience
in technological innovation in the field has made him a valuable
leader as PacBio launched and scaled its technology to where it is
today."
"It has been an honor to work alongside the PacBio leadership
team for more than 11 years, and I have never been more excited
about the prospects for PacBio and its technology than I am today,"
added David Botstein. "I leave the
Board with a world-class leadership team that I believe will
continue to execute on its goal of becoming a multi-omic leader in
the life sciences industry."
About PacBio
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier
life science technology company that is designing, developing, and
manufacturing advanced sequencing solutions that enable scientists
and clinical researchers to improve their understanding of the
genome and ultimately, resolve genetically complex problems. Our
products and technology under development stem from two highly
differentiated core technologies focused on accuracy, quality, and
completeness, which include our existing HiFi long-read sequencing
technology and our emerging short-read Sequencing by Binding (SBB™)
technology. Our products address solutions across a broad set of
applications, including human genomics, plant and animal sciences,
infectious disease and microbiology, oncology, and other emerging
applications. For more information, please visit www.pacb.com and
follow @PacBio.
PacBio products are provided for research use only. Not for use
in diagnostic procedures.
Contacts
Investors:
Todd
Friedman
650.521.8450
ir@pacb.com
Media:
Lizelda Lopez
pr@pacb.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pacbio-announces-the-retirement-of-david-botstein-phd-from-its-board-of-directors-302010982.html
SOURCE Pacific Biosciences of California, Inc.